Due to the modern, fast-paced lifestyle, people across Qatar are facing a lot of chronic health issues. These include obesity, diabetes, and other cardiovascular diseases. The rising prevalence of chronic diseases among the rapidly growing population of Qatar has raised a huge demand in the pharmaceutical market.

The increasing expenditure for healthcare operations along with the smaller size of the pharma market in Qatar is further aggravating the problems. As a result, Qatar has to rely vastly on Imports from other countries.

That’s where the Indian exporters come into play. Indian pharma companies like Neumedica Healthcare have readily available raw materials and skilled workforce along with world-class machinery. This helps them export top quality pharma products at prices that are lower than other pharmaceutical companies in Qatar.

Moreover, India is the world leader when it comes to the export of generic medicines and biosimilars. These generics can define the future of Qatar’s pharmaceutical sector. They can help to reduce the expenditures due to the increasing cost of patented drugs.

With the vast industrial experience along with unparalleled cost-effectiveness, Indian pharmaceutical companies can help Qatar meet its health goals in the near future.